AMGN Stock Recent News

The U.S. Food and Drug Administration will send out around 100 cease-and-desist enforcement notices and thousands of letters warning pharmaceutical companies that direct-to-consumer ads must comply with regulations that are already on the books, senior administration officials said on Tuesday.

Amgen Inc. (NASDAQ:AMGN ) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 9:15 AM EDT Company Participants Peter Griffith - Executive VP & CFO Kave Niksefat - Senior Vice President of Global Marketing & Access Conference Call Participants Terence Flynn - Morgan Stanley, Research Division Presentation Terence Flynn Equity Analyst Great. Good morning, everybody.

THOUSAND OAKS, Calif. and TOKYO, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Amgen (NASDAQ:AMGN) and Kyowa Kirin Co., Ltd. (TSE:4151) today announced preliminary top-line results from the ASCEND study evaluating rocatinlimab, an investigational T-cell rebalancing therapy targeting the OX40 receptor, in adults and adolescents with moderate to severe atopic dermatitis (AD).

Quick -- what were you doing back in September of 2022? Were you buying $10,000 of stock in Amgen (AMGN -1.17%)?

In the most recent trading session, Amgen (AMGN) closed at $280.19, indicating a -1.22% shift from the previous trading day.

THOUSAND OAKS, Calif. and TOKYO , Sept.

--> --> Key Points Nvidia’s (NVDA) $600 million investment in Quantinuum values the quantum firm at $10 billion, doubling its prior valuation. Major investors like JPMorgan and Mitsui joined the round, reflecting strong market confidence in quantum computing. NVDA CEO Jensen Huang’s revised outlook highlights quantum’s nearing practicality, potentially boosting quantum computing stocks. Nvidia made early investors rich, but there is a new class of ‘Next Nvidia Stocks’ that could be even better. Click here to learn more. --> --> Nvidia’s Quantum Leap Signals Industry Momentum Nvidia’s (NASDAQ:NVDA) venture capital arm, NVentures, recently joined a $600 million funding round for Quantinuum, a quantum computing firm majority-owned by Honeywell (NYSE:HON), valuing it at an impressive $10 billion. This investment doubles Quantinuum’s valuation from $5 billion in January 2024, reflecting surging investor confidence in quantum technology’s potential. Alongside Nvidia, major

Verizon stands out as the only Dow stock meeting the 'dogcatcher' ideal: annual dividends from $1K invested exceed its share price and are well-covered. Analyst forecasts suggest top Dow Dogs could deliver 13-31% net gains by September 2026, with an average 19.4% return and lower-than-market volatility. Most Dow dividend stocks remain too expensive relative to their yields; market corrections or dividend hikes are needed for broader fair-value opportunities.

THOUSAND OAKS, Calif. , Sept. 4, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Morgan Stanley 23rd Annual Global Healthcare Conference at 9:15 a.m.

Global drugmakers are scrambling to shore up their U.S. manufacturing capacity and domestic inventory as the Trump administration weighs hefty tariffs on pharmaceutical imports into the country.